Development and Manufacture of Pharmaceutical Dosage Forms for Treatment of Substance Abuse Disorders

Location: Federal
Posted: Feb 17, 2026
Due: Mar 4, 2026
Agency: HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Type of Government: Federal
Category:
  • A - Research and development
Solicitation No: 75N98026R00007SB
Publication URL: To access bid details, please log in.
Follow
Development and Manufacture of Pharmaceutical Dosage Forms for Treatment of Substance Abuse Disorders
Active
Contract Opportunity
Notice ID
75N98026R00007SB
Related Notice
Department/Ind. Agency
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier
NATIONAL INSTITUTES OF HEALTH
Office
NATIONAL INSTITUTES OF HEALTH NIDA
Looking for contract opportunity help?

APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.

APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.

The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).

General Information
  • Contract Opportunity Type: Sources Sought (Original)
  • Original Published Date: Feb 17, 2026 11:24 am EST
  • Original Response Date: Mar 04, 2026 09:00 am EST
  • Inactive Policy: Manual
  • Original Inactive Date: Mar 04, 2026
  • Initiative:
    • None
Classification
  • Original Set Aside:
  • Product Service Code: AN11 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
  • NAICS Code:
    • 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
  • Place of Performance:
    USA
Description

The National Institute on Drug Abuse (NIDA) is soliciting proposals from qualified organizations having the capability to carry out development of formulations, manufacture, quality control tests, stability studies and distribution of pharmaceutical drug products to be used in the medications development program for treating substance use disorders. Development of medications for the treatment of substance use disorders is a major mission of NIDA. Some of the potential treatment drugs currently being investigated are new chemical entities and previously approved drug substances. The Government acquires these drug substances from private industries, Government contractors/grantees, or independent investigators. This contract is to provide the Government a resource for the development and manufacture of pharmaceutical dosage forms for use in preclinical and clinical studies. Please see SSN attached.


Attachments/Links
Contact Information
Contracting Office Address
  • c/o 3WFN MSC 6012 301 N Stonestreet Ave
  • Bethesda , MD 20892
  • USA
Primary Point of Contact
Secondary Point of Contact
History
  • Feb 17, 2026 11:24 am ESTSources Sought (Original)
Daily notification on new contract opportunities

With GovernmentContracts, you can:

  • Find more opportunities and win more business
  • Receive daily alerts for all new bid opportunities
  • Get contract opportunities matched to your business
ONE WEEK FREE TRIAL

See also

...: Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS ...

VETERANS AFFAIRS, DEPARTMENT OF

Bid Due: 6/18/2026

...for a program to test the contractor's employees for drugs in accordance with ...

MPN

Bid Due: 3/31/2074

...diagnostic tests and treatments for cancer and AIDS. FNLCR is a multi-program laboratory ...

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Bid Due: 6/18/2026

* Disclaimer: Information regarding bids, requests for proposals (RFPs), or requests for qualifications (RFQs) is provided on this website only for convenience and does not constitute official public notice. Persons wishing to respond to or inquire about bids, RFPs, or RFQs should contact the appropriate government department.